One-stop Complement Therapeutic Development & Complement-based Drug Discovery. Inquire! For Complement Therapeutics. With Advanced Technology & Rich Experience. Inquire Now!
- Checkpoint Antibody
Antibody Discovery and Development
Antibody for Cancer Therapy
- Antibody Development...
Learn More About-Therapeutic
Antibody Development Services.
- Regulator Development
Soluble Complement
Complement Regulator
- Complement Test Services
Complement Function Analysis
Complement Function Analysis
- Checkpoint Antibody
Suchergebnisse
Suchergebnisse:
[2] Steg G, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569–2619. [3] Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013; 34: 2949–3003.
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. 2018 ESC/EACTS Guidelines on myocardial revascularization. 2018 ESC Guidelines on Universal Definition of Myocardial Infarction. 2018 ESC Guidelines for the diagnosis and management of syncope. 2017. 2017 ESC/EACTS Guidelines for the management of valvular heart ...
25. Aug. 2018 · 3. Introduction. In the late 19th century, postmortem examinations demonstrated a possible relationship between thrombotic occlusion of a coronary artery and myocardial infarction (MI). 1 However, it was not until the beginning of the 20th century that the first clinical descriptions appeared describing a connection between the formation of a thrombus in a coronary artery and its associated ...
26. Aug. 2023 · Amsterdam, Netherlands – 26 Aug 2023: Physiology-guided complete revascularisation reduces ischaemic events compared with culprit-only revascularisation in myocardial (MI) infarction patients aged 75 years or older with multivessel disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2023. 1.
25 Aug 2021. The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence. Fortunately, we now have a wealth of clinical trials to help us select the best management to improve the outcomes for people with HF; for many, it is now both preventable and treatable.
1. Nov. 2017 · Post-myocardial infarction pericarditis can be differentiated into early infarct-associated pericarditis and late post-myocardial infarction pericarditis, also known as Dressler’s syndrome. The former occurs within five days after myocardial infarction. With an incidence of <5% it has become quite rare in developed countries. A major risk factor is delayed angioplasty. The risk of recurrence ...
21 Aug 2020. The current Guidelines for exercise and sports participation in individuals with CVD are the first of a kind by the ESC. Sports cardiology is a relatively novel and emerging sub-speciality, therefore the evidence base for the natural history of disease progression or risk of death during intensive exercise and competitive sport ...
